European Heart Journal: Acute Cardiovascular Care最新文献

{"title":"Breaking barriers, bridging gaps, and redefining acute cardiovascular care: May issue highlights.","authors":"Pascal Vranckx, David A Morrow, Sean van Diepen, Frederik H Verbrugge","doi":"10.1093/ehjacc/zuaf062","DOIUrl":"10.1093/ehjacc/zuaf062","url":null,"abstract":"","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":"257-258"},"PeriodicalIF":3.9,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143984047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impressions and voices from the Acute CardioVascular Care congress 2025.","authors":"Michelle Roßberg, Milica Aleksic, Janine Pöss, Alessandro Galluzzo","doi":"10.1093/ehjacc/zuaf047","DOIUrl":"10.1093/ehjacc/zuaf047","url":null,"abstract":"","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":"308-309"},"PeriodicalIF":3.9,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143763474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Early sedation with dexmedetomidine in patients with acute myocardial infarction requiring mechanical ventilation.","authors":"Soumya Banna, Christopher Schenck, Avinainder Singh, Israel Safiriyu, Jose Victor Jimenez, Ashley Franko, Alexander Thomas, Cory Heck, Jonathan Ludmir, Ann Gage, Tariq Ali, Jason N Katz, David M Dudzinski, Joseph S Ross, P Elliott Miller","doi":"10.1093/ehjacc/zuaf022","DOIUrl":"10.1093/ehjacc/zuaf022","url":null,"abstract":"<p><strong>Aims: </strong>Patients with acute myocardial infarction (AMI) who require invasive mechanical ventilation (IMV) represent a critically ill population with limited data on optimal sedative and analgesic use. Clinical trials assessing dexmedetomidine use exclude poorly represent patients with AMI. This study aimed to compare the use of early sedation with dexmedetomidine with usual care sedation in patients with AMI requiring IMV.</p><p><strong>Methods and results: </strong>We utilized the Vizient® Clinical Data Base to identify patients aged ≥18 years admitted between 2015 and 2019 with a primary diagnosis of AMI who required IMV. Patients receiving dexmedetomidine on the first day of IMV were included in the early dexmedetomidine group, while the remaining patients were assigned to the usual care group. Inverse probability of treatment weighting (IPTW) was used to estimate adjusted risk differences between groups. We identified 15 928 patients, of which 1620 (10.2%) received early dexmedetomidine. Patients who received early dexmedetomidine were more likely to present with cardiogenic shock (52.0 vs. 47.7%, P = 0.001). In unadjusted analyses, patients receiving early dexmedetomidine had lower in-hospital mortality (33.0 vs. 42.1%) and more ventilator-free days (13.6 vs. 12.1) compared with usual care (both, P < 0.05). After IPTW, patients receiving early dexmedetomidine had an 11.0% [95% confidence interval (CI): 8.6-13.5%] lower mortality and more ventilator-free days (mean difference: +2.2 days, 95% CI: 1.6-2.8 days).</p><p><strong>Conclusion: </strong>Early sedation with dexmedetomidine was associated with lower mortality compared with usual care in patients with AMI requiring IMV. A randomized controlled trial of sedative agents in this population is warranted.</p>","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":"270-278"},"PeriodicalIF":3.9,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143370733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Resource utilization associated with extracorporeal membrane oxygenation vs. microaxial flow pump for infarct-related cardiogenic shock.","authors":"Margriet Bogerd, Luc Ten Hoorn, Sanne Ten Berg, Elma J Peters, Annemarie E Engström, Arjan Malekzadeh, Holger Thiele, Jacob E Møller, Christian Hassager, Alexander P J Vlaar, José P S Henriques","doi":"10.1093/ehjacc/zuaf024","DOIUrl":"10.1093/ehjacc/zuaf024","url":null,"abstract":"<p><strong>Aims: </strong>Microaxial flow pump and venoarterial extracorporeal membrane oxygenation (VA-ECMO) are increasingly used in infarct-related cardiogenic shock. This study provides a comparative overview of real-world resource utilization associated with these devices (PROSPERO: CRD42024505174).</p><p><strong>Methods and results: </strong>EMBASE, MEDLINE, and Cochrane Library were sought from inception to 13 November 2024 for studies reporting at least one primary outcome, including intensive care unit (ICU) length of stay (LOS), hospital LOS, in-hospital costs, and discharge destination. In-hospital mortality was included as secondary outcome. This study was guided by the PRISMA-2020 guideline. Study selection and data extraction were independently performed by two researchers. Risk-of-bias assessments were done using the Newcastle-Ottawa-Scale. Data were pooled using random-effect models. In total, 12 retrospective cohorts were identified encompassing 92 262 microaxial flow pump- and 16 474 VA-ECMO patients data. The meta-analysis of hospital LOS and in-hospital costs revealed favourable results for the microaxial flow pump, with mean differences (MD) of -5.3 days (95% CI: -6.6, -4.1) and -$113 983 (95% CI: -$143 153, -$84 812), respectively. Microaxial flow pump survivors were also 45% more likely to be discharged home (95% CI: 1.28-1.64). Intensive care unit-length of stay was reported by one study, reporting a 10 days MD in favour of the microaxial flow pump. The averaged in-hospital mortality rates were 44% and 57% for the microaxial flow pump and VA-ECMO, respectively. An inherent limitation of observational studies is confounding by indication.</p><p><strong>Conclusion: </strong>Microaxial flow pump was associated with lower resource utilization compared with VA-ECMO. Resource utilization should be incorporated in prospective RCTs and taken into account when considering these devices.</p>","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":"279-287"},"PeriodicalIF":3.9,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12082289/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143406453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Telecardiology unleashed: probing the depths of effectiveness in remote monitoring and telemedicine applications for acute cardiac conditions.","authors":"Michiel De Wever, Henri Gruwez, Sebastiaan Dhont, Laurent Pison, Pieter Vandervoort, Peter Haemers","doi":"10.1093/ehjacc/zuaf060","DOIUrl":"https://doi.org/10.1093/ehjacc/zuaf060","url":null,"abstract":"<p><p>Telecardiology has emerged as a promising approach in acute cardiac care through advancements in digital health technologies. This review explores the current evidence of telemedicine applications in acute coronary syndrome, arrhythmias, and acute heart failure. Telecardiology strategies are already implemented in clinical practice today. Examples such as pre-hospital electrocardiogram transmission and remote monitoring using non-invasive and invasive devices have shown to enhance diagnostic accuracy, reduce treatment delays, and improve outcomes. However, despite multiple meta-analyses, the effectiveness of telecardiology remains uncertain due to heterogeneity in study designs and lack of high-quality randomized controlled trials. Increasingly, the integration of artificial intelligence offers unprecedented opportunities for diagnostic precision, predictive analytics, and personalized care yet requires rigorous validation and ethical considerations. This article underscores the pivotal role of the cardiologist in bridging the gaps between technology and clinical practice by providing an evidence-based scaffold on telecardiology effectiveness and clinical implementation.</p>","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":"14 5","pages":"295-303"},"PeriodicalIF":3.9,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144076742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Question: Triphasic radial pulse in a patient with abdominal pain.","authors":"Jonathan Chun-Hei Cheung, Geoffrey Chi Chun Tang, Albert Kam Ming Chan","doi":"10.1093/ehjacc/zuae128","DOIUrl":"10.1093/ehjacc/zuae128","url":null,"abstract":"","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":"304-305"},"PeriodicalIF":3.9,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143482449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diabetes in resuscitated comatose out-of-hospital cardiac arrest patients - A substudy of the randomized BOX trial.","authors":"Jakob Josiassen, Jacob E Møller, Henrik Schmidt, Rasmus P Beske, Johannes Grand, Jesper Kjaergaard, Christian Hassager","doi":"10.1093/ehjacc/zuaf073","DOIUrl":"https://doi.org/10.1093/ehjacc/zuaf073","url":null,"abstract":"<p><strong>Background and objectives: </strong>This study aimed to assess mortality rates in resuscitated comatose out-of-hospital cardiac arrest patients with and without diabetes randomized to targets of blood pressure, oxygen and duration of fever prevention.</p><p><strong>Methods: </strong>Diabetic and non-diabetic patients from the BOX trial was compared. The BOX trial was a randomized, controlled, multi-centre study comparing two mean arterial blood pressure targets (63vs77 mm Hg) in a double-blinded intervention and two open labelled targets including a liberal and restrictive oxygenation (9-10vs13-14 kPa) target and two regimes for length of fever-control (36vs72 hours). The primary outcome for this substudy is 365-day survival. Multiple logistic regression models were used to adjust for factors known to be associated with outcome including age, sex, witnessed arrest (y/n) and time to return of spontaneous circulation (min).</p><p><strong>Results: </strong>A total of 110 (14%) patients had preexisting diabetes. Compared to the non-diabetic group, the patients with diabetes were older (median years (IQR) 67 (59;73)) vs 63 (53;72)) and had more comorbidities.The diabetic patients had an overall increased 365-day all-cause mortality (45 % vs 34 %, p=0.02). The logistic regression model adjusting for age and sex, witnessed arrest (y/n) and place of arrest of arrest gave an estimated adjusted odds ratio of 1.47 (0.93-2.30), p=0.10. No significant interactions were observed among interventions and outcomes related to diabetes status, p ranging from 0.10 to 0.80.</p><p><strong>Conclusions: </strong>Preexisting diabetes was associated with an increased crude 365-day mortality. No differences in outcome were observed among diabetic OHCA patients depending on the assessed blood pressure targets, oxygen levels and durations of fever control.</p>","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143985811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prognostic factors for out-of-hospital cardiac arrest patients with prolonged low-flow time undergoing extracorporeal cardiopulmonary resuscitation.","authors":"Kasumi Shirasaki, Masaki Okajima, Tasuku Hada, Shutaro Isokawa, Akihiko Inoue, Tetsuya Sakamoto, Yasuhiro Kuroda, Tadashi Toyama, Toru Hifumi, Norio Otani","doi":"10.1093/ehjacc/zuaf072","DOIUrl":"https://doi.org/10.1093/ehjacc/zuaf072","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to examine factors associated with favourable neurological outcomes in out-of-hospital cardiac arrest (OHCA) patients with low-flow time (LFT) exceeding 60 minutes following extracorporeal cardiopulmonary resuscitation (ECPR).</p><p><strong>Methods: </strong>This was a secondary analysis of the SAVE-J II study, a retrospective, multicentre, registry study involving 36 participating institutions in Japan. OHCA patients ≥18 years old who underwent ECPR in Japan between January, 2013 and December, 2018 were registered. This study selected the non-hypothermic patients with LFT ≥ 60 minutes. The primary outcome was a favourable neurological outcome (cerebral performance categories 1-2). Multivariable logistic regression analyses were performed to assess the factors associated with a favourable neurological outcome.</p><p><strong>Results: </strong>In total, 708 patients met the inclusion criteria, with favourable neurological outcomes at hospital discharge in 71 cases (10.0%). Age, shockable rhythm on hospital arrival, signs of life (SOLs) on hospital arrival, and transient return of spontaneous circulation (ROSC) were significantly associated with a favourable neurological outcome.</p><p><strong>Conclusions: </strong>Approximately 10% of OHCA patients who underwent ECPR with LFT ≥ 60 minutes had favourable neurological outcomes. ECPR for non-hypothermic OHCA patients might be considered even with prolonged LFT based on age, shockable rhythm on hospital arrival, SOLs on hospital arrival, and presence of transient ROSC before ECMO initiation.</p>","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143992825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Acute and long-term outcomes of patients with high-risk pulmonary embolism treated with advanced therapies.","authors":"Andreas Verstraete, Pascal Frederiks, Lorenz Van der Linden, Tom Verbelen, Peter Verhamme, Thomas Vanassche","doi":"10.1093/ehjacc/zuaf071","DOIUrl":"https://doi.org/10.1093/ehjacc/zuaf071","url":null,"abstract":"","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144119086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Role of sub-clinical inflammation and defective cholesterol efflux in myocardial infarction patients without standard modifiable risk factors.","authors":"Vincent Roule, Farzin Beygui, Maryse Guerin, Clément Materne, Niki Procopi, Ghilas Rahoual, Paul Guedeney, Michel Zeitouni, Mathieu Kerneis, Gilles Montalescot, Johanne Silvain","doi":"10.1093/ehjacc/zuaf070","DOIUrl":"https://doi.org/10.1093/ehjacc/zuaf070","url":null,"abstract":"<p><strong>Background and aims: </strong>Sub-clinical inflammation and defective high-density lipoprotein (HDL) function have emerged as potential risk factors for a first cardiovascular event. We evaluated their role in the pathogenesis of ST-segment elevation myocardial infarction (STEMI) patients with no standard modifiable cardiovascular risk factors (SMuRF).</p><p><strong>Methods: </strong>Using our STEMI biobank registry, we compared baseline characteristics and markers of sub-clinical inflammation (interleukin (IL)-1β, high sensitivity C Reactive Protein (hsCRP) and defective HDL function using serum cholesterol efflux capacity) in patients with and without SMuRF. Determinants of 1-year all-cause mortality were assessed using multivariable Cox regression analyses.</p><p><strong>Results: </strong>Among the 1604 patients included, 178 (11.1%) were SMuRF-less. Compared to patients with SMuRF, SMuRF-less patients had lower serum cholesterol efflux capacity (0.79 ± 0.16 vs 0.83 ± 0.16, respectively, p<0.001), were more often in the highest tertile of IL-1β (28.7% vs 18.9%, respectively, p=0.002) with a trend towards more patients within the highest hs-CRP level tertile (24.7% vs 19.1%, respectively, p=0.077). Crude rates of mortality were higher in the SMuRF-less group (18.5% vs 7.7%, p<0.001). After multivariable adjustment with traditional prognostic risk factors, high tertiles of hs-CRP (HR 1.83 (1.28-2.63), p=0.001) or of IL-1β (HR 1.54 (1.06-2.24), p=0.024), and SMuRF-less status (HR 1.56 (1.05-2.38), p=0.029) were associated with mortality while higher serum cholesterol efflux capacity was protective (HR 0.27 (0.09-0.87); p=0.028).</p><p><strong>Conclusion: </strong>Sub clinical inflammation and defective cholesterol efflux were associated with SMuRF-less status of STEMI patients and had prognostic impact. This highlights the need to explore new therapeutic strategies in this high-risk population.</p>","PeriodicalId":11861,"journal":{"name":"European Heart Journal: Acute Cardiovascular Care","volume":" ","pages":""},"PeriodicalIF":3.9,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143959429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}